BIOPURE AVOIDS SEC FINE

Biopure Corp. won't have to pay penalties to settle allegations it touted the prospects for a synthetic blood product without disclosing that drug regulators had concerns about the product's safety, the Securities and Exchange Commission said Tuesday.
Yahoo Finance